These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 39234749)
1. The diagnostic value of serum trefoil factor 3 and pepsinogen combination in chronic atrophic gastritis: a retrospective study based on a gastric cancer screening cohort in the community population. Zhao J; Tian W; Zhang X; Dong S; Shen Y; Gao X; Yang M; Lv J; Hu F; Han J; Zhan Q; An F Biomarkers; 2024 Sep; 29(6):384-392. PubMed ID: 39234749 [TBL] [Abstract][Full Text] [Related]
2. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China. Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760 [TBL] [Abstract][Full Text] [Related]
3. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780 [TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis]. Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172 [TBL] [Abstract][Full Text] [Related]
5. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254 [TBL] [Abstract][Full Text] [Related]
6. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran. Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854 [TBL] [Abstract][Full Text] [Related]
8. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568 [TBL] [Abstract][Full Text] [Related]
9. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg. Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521 [TBL] [Abstract][Full Text] [Related]
11. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q; Ran ZH; Xiao SD J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130 [TBL] [Abstract][Full Text] [Related]
12. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy. Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma]. Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174 [TBL] [Abstract][Full Text] [Related]
14. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. Tong Y; Wu Y; Song Z; Yu Y; Yu X BMC Gastroenterol; 2017 Jul; 17(1):88. PubMed ID: 28728545 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects. Dondov G; Amarbayasgalan D; Batsaikhan B; Badamjav T; Batbaatar B; Tuvdenjamts B; Tumurbat N; Davaa B; Purevdorj E; Nyamaa B; Lonjid T PLoS One; 2022; 17(10):e0274938. PubMed ID: 36251649 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668 [TBL] [Abstract][Full Text] [Related]
17. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis. Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884 [TBL] [Abstract][Full Text] [Related]
18. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. Sun LP; Gong YH; Wang L; Yuan Y World J Gastroenterol; 2007 Dec; 13(48):6562-7. PubMed ID: 18161928 [TBL] [Abstract][Full Text] [Related]
19. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714 [TBL] [Abstract][Full Text] [Related]
20. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference. Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]